Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights
Eli Lilly ($LLY) reported Q2 2026 earnings, beating estimates with revenue of $23.0B and adjusted EPS of $8.38. The company also raised its full-year 2026 guidance, projecting EPS of $35.50–$36.50 and revenue of $85B–$87B.
Ask about this postAnswers are grounded in this post's content.
Tweet
About Mando
Mando
By rektmando
@yeet @rektbrands @epikduckcoin https://t.co/FvpLCBikME #1 Newsletter in Crypto: https://t.co/7EJrnNhDKV